ArticlePharmacy (Basel, Switzerland)2025

Insulin Glargine Biosimilar Prescribing and Cost Trends in the United Kingdom's Primary Care from 2020 to 2024.

Murtada Alsaif et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.